Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedJun 21, 2024
DataAggregated Company Financials
Companies31
  • 7D4.1%
  • 3M14.7%
  • 1Y-20.3%
  • YTDn/a

In the last week, the Biotech industry is up 8.4%, with SanBio up 139%. Meanwhile, 3-D Matrix actually underperformed within the industry, shrinking 19% in the last week. In the past year, the industry is down 20%. As for the next few years, earnings are expected to grow by 20% per annum.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 22 Jun 2024JP¥904.7bJP¥187.7b-JP¥15,773,284,000.0082.7x-57.4x4.8x
Mon, 20 May 2024JP¥769.6bJP¥195.9b-JP¥13,410,545,000.0093.1x-57.4x3.9x
Wed, 17 Apr 2024JP¥738.7bJP¥194.2b-JP¥15,746,877,000.0065.5x-46.9x3.8x
Fri, 15 Mar 2024JP¥770.9bJP¥194.2b-JP¥18,497,703,000.0058.4x-41.7x4x
Sun, 11 Feb 2024JP¥747.3bJP¥222.2b-JP¥12,699,799,000.0016.7x-58.8x3.4x
Tue, 09 Jan 2024JP¥803.0bJP¥222.3b-JP¥12,668,455,000.0017.4x-63.4x3.6x
Thu, 07 Dec 2023JP¥792.3bJP¥221.9b-JP¥12,426,487,000.0016.7x-63.8x3.6x
Sat, 04 Nov 2023JP¥746.6bJP¥223.0b-JP¥14,350,085,000.0019.3x-52x3.3x
Mon, 02 Oct 2023JP¥847.8bJP¥223.0b-JP¥14,518,735,000.0026.2x-58.4x3.8x
Wed, 30 Aug 2023JP¥928.5bJP¥225.1b-JP¥19,814,131,000.0050.4x-46.9x4.1x
Fri, 28 Jul 2023JP¥908.4bJP¥223.7b-JP¥20,836,669,000.0049.7x-43.6x4.1x
Sun, 25 Jun 2023JP¥973.0bJP¥223.2b-JP¥20,139,670,000.0064.6x-48.3x4.4x
Tue, 23 May 2023JP¥916.3bJP¥218.6b-JP¥25,244,669,000.0032.1x-36.3x4.2x
Thu, 20 Apr 2023JP¥946.1bJP¥218.1b-JP¥20,115,522,000.0021.5x-47x4.3x
Sat, 18 Mar 2023JP¥935.3bJP¥218.1b-JP¥20,708,580,000.0020.9x-45.2x4.3x
Mon, 13 Feb 2023JP¥957.1bJP¥200.4b-JP¥25,348,917,000.0038.1x-37.8x4.8x
Wed, 11 Jan 2023JP¥902.6bJP¥186.8b-JP¥24,722,604,000.0041x-36.5x4.8x
Fri, 09 Dec 2022JP¥897.7bJP¥186.6b-JP¥26,666,433,000.0044.6x-33.7x4.8x
Sun, 06 Nov 2022JP¥813.4bJP¥176.5b-JP¥24,989,270,000.0046.8x-32.5x4.6x
Tue, 04 Oct 2022JP¥865.7bJP¥176.5b-JP¥24,974,270,000.0043.3x-34.7x4.9x
Thu, 01 Sep 2022JP¥955.2bJP¥174.4b-JP¥21,144,270,000.0021.9x-45.2x5.5x
Sat, 30 Jul 2022JP¥980.3bJP¥171.3b-JP¥16,251,673,000.0021.2x-60.3x5.7x
Mon, 27 Jun 2022JP¥879.1bJP¥171.3b-JP¥16,112,943,000.0020.6x-54.6x5.1x
Wed, 25 May 2022JP¥915.9bJP¥169.3b-JP¥13,349,721,000.0011.3x-68.6x5.4x
Fri, 22 Apr 2022JP¥1.0tJP¥164.2b-JP¥13,043,295,000.0014.4x-78.2x6.2x
Sun, 20 Mar 2022JP¥1.1tJP¥164.2b-JP¥13,044,654,000.0015.2x-82.4x6.5x
Tue, 15 Feb 2022JP¥1.1tJP¥160.0b-JP¥7,063,120,000.0015.7x-149.9x6.6x
Thu, 13 Jan 2022JP¥1.2tJP¥163.5b-JP¥5,447,358,000.0018.2x-222.1x7.4x
Sat, 11 Dec 2021JP¥1.2tJP¥163.7b-JP¥6,105,358,000.0018.3x-202.9x7.6x
Mon, 08 Nov 2021JP¥1.4tJP¥148.1b-JP¥15,446,127,000.0025.4x-90.8x9.5x
Wed, 06 Oct 2021JP¥1.5tJP¥147.6b-JP¥12,269,440,000.0023.4x-118.2x9.8x
Fri, 03 Sep 2021JP¥1.7tJP¥148.3b-JP¥14,096,440,000.0025.9x-120x11.4x
Sun, 01 Aug 2021JP¥1.6tJP¥148.3b-JP¥14,096,440,000.0021.9x-115.8x11x
Price to Earnings Ratio

-122.9x


Total Market Cap: JP¥1.9tTotal Earnings: -JP¥15,500,440,000.00Total Revenue: JP¥139.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Biotech Industry Price to Earnings3Y Average -73.1x202220232024
Current Industry PE
  • Investors are pessimistic on the Japanese Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.6x is higher than the industry's current PS ratio of 4.8x.
Past Earnings Growth
  • Losses for companies in the Biotechnology industry have mostly stayed the same over the last three years.
  • Meanwhile revenues for these companies have grown 10% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, losses haven't seen much improvement.

Industry Comparison

How does Japanese Biotech compare with similar industries?

JP Market-0.038%
Healthcare-0.86%
Biotech4.12%
Biotech4.12%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4587 PeptiDreamJP¥2.27k3.5%
+JP¥9.9b
3.6%PE120.6x
2160 GNI GroupJP¥2.46k7.4%
+JP¥8.5b
63.1%PE12.9x
4974 Takara BioJP¥1.04k3.4%
+JP¥4.1b
-36.1%PE84.8x
4593 Healios K.KJP¥189.0012.5%
+JP¥1.9b
-33.2%PS137.4x
4891 TMSJP¥234.006.8%
+JP¥604.6m
-24.5%PB2.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4594

JP¥55.00

BrightPath Biotherapeutics

7D

-14.1%

1Y

-58.0%

4592

JP¥698.00

SanBio

7D

-9.9%

1Y

6.4%

4891

JP¥234.00

TMS

7D

6.8%

1Y

-24.5%

7777

JP¥124.00

3-D Matrix

7D

-10.8%

1Y

-35.8%

4599

JP¥373.00

StemRIM

7D

-8.6%

1Y

-63.3%

190A

JP¥147.00

Chordia Therapeutics

7D

-23.4%

1Y

n/a

4974

JP¥1,042.00

Takara Bio

7D

3.4%

1Y

-36.1%

2929

JP¥998.00

Pharma Foods International

7D

1.3%

1Y

-54.5%

4593

JP¥189.00

Healios K.K

7D

12.5%

1Y

-33.2%

4587

JP¥2,272.00

PeptiDream

7D

3.5%

1Y

3.6%

7776

JP¥226.00

CellSeed

7D

-8.9%

1Y

-35.8%

177A

JP¥1,833.00

Kohjin Bio

7D

6.3%

1Y

n/a

4564

JP¥32.00

OncoTherapy Science

7D

6.7%

1Y

-23.8%